These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33447334)

  • 21. Epidemiological trends of Lassa fever in Nigeria, 2018-2021.
    Dalhat MM; Olayinka A; Meremikwu MM; Dan-Nwafor C; Iniobong A; Ntoimo LF; Onoh I; Mba S; Ohonsi C; Arinze C; Esu EB; Nwafor O; Oladipupo I; Onoja M; Ilori E; Okonofua F; Ochu CL; Igumbor EU; Adetifa I
    PLoS One; 2022; 17(12):e0279467. PubMed ID: 36584167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Descriptive epidemiology of Lassa fever in Nigeria, 2012-2017.
    Okoro OA; Bamgboye E; Dan-Nwafor C; Umeokonkwo C; Ilori E; Yashe R; Balogun M; Nguku P; Ihekweazu C
    Pan Afr Med J; 2020; 37():15. PubMed ID: 33062117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice.
    Fisher-Hoch SP; Tomori O; Nasidi A; Perez-Oronoz GI; Fakile Y; Hutwagner L; McCormick JB
    BMJ; 1995 Sep; 311(7009):857-9. PubMed ID: 7580496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying the seasonal drivers of transmission for Lassa fever in Nigeria.
    Akhmetzhanov AR; Asai Y; Nishiura H
    Philos Trans R Soc Lond B Biol Sci; 2019 Jun; 374(1775):20180268. PubMed ID: 31056054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogens that Cause Illness Clinically Indistinguishable from Lassa Fever, Nigeria, 2018.
    Ashcroft JW; Olayinka A; Ndodo N; Lewandowski K; Curran MD; Nwafor CD; Madubuike K; Bagnall H; Musa AS; Ahmad A; Akinpelu A; Adeleye A; Martin C; Akano A; Onoja M; Iniobong A; Ukponu W; Arinze C; Ilori E; Mba N; Gannon B; Ahumibe A; Ihekweazu C
    Emerg Infect Dis; 2022 May; 28(5):994-997. PubMed ID: 35226800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving Cross-Border Preparedness and Response: Lessons Learned from 3 Lassa Fever Outbreaks Across Benin, Nigeria, and Togo, 2017-2019.
    Kakaī CG; Okunromade OF; Dan-Nwafor CC; Chabi AIB; Martial GTP; Dalhat MM; Ward S; Tante O; Nguku PM; Hamadi A; Ilori E; Lokossou V; Brito C; Ojo OE; Kone I; Agbeko TT; Ihekweazu C; Merrill RD
    Health Secur; 2020 Jan; 18(S1):S105-S112. PubMed ID: 32004125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lassa fever-induced sensorineural hearing loss: A neglected public health and social burden.
    Mateer EJ; Huang C; Shehu NY; Paessler S
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006187. PubMed ID: 29470486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rapid research needs appraisal methodology to identify evidence gaps to inform clinical research priorities in response to outbreaks-results from the Lassa fever pilot.
    Sigfrid L; Moore C; Salam AP; Maayan N; Hamel C; Garritty C; Lutje V; Buckley B; Soares-Weiser K; Marshall R; Clarke M; Horby P
    BMC Med; 2019 Jun; 17(1):107. PubMed ID: 31185979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early onset of neurological features differentiates two outbreaks of Lassa fever in Ebonyi state, Nigeria during 2017-2018.
    Chika-Igwenyi NM; Harrison RE; Psarra C; Gil-Cuesta J; Gulamhusein M; Onwe EO; Onoh RC; Unigwe US; Ajayi NA; Nnadozie UU; Ojide CK; Nwidi DU; Ezeanosike O; Sampson E; Adeke AS; Ugwu CN; Anebonam U; Tshiang JK; Maikere J; Reid A
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009169. PubMed ID: 33684118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and outcome of Lassa fever among hospitalized patients in Ebonyi State, Nigeria, 2018-2019.
    Nwafor IE; Ogah OE; Ojide CK; Odeh EC; Abu AM; Chika-Igwenyi NM; Nwidi DU; Unigwe US; Ajayi NA; Eke MAS; Obasi MN; Adeke AS; Onyia V; Duruiheoma R; Igboke NC; Otti J; Ogbu O
    Virus Res; 2020 Aug; 285():198000. PubMed ID: 32380207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knowledge and risk perception towards Lassa fever infection among residents of affected communities in Ebonyi State, Nigeria: implications for risk communication.
    Usuwa IS; Akpa CO; Umeokonkwo CD; Umoke M; Oguanuo CS; Olorukooba AA; Bamgboye E; Balogun MS
    BMC Public Health; 2020 Feb; 20(1):217. PubMed ID: 32050926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nigeria hit by unprecedented Lassa fever outbreak.
    Roberts L
    Science; 2018 Mar; 359(6381):1201-1202. PubMed ID: 29590055
    [No Abstract]   [Full Text] [Related]  

  • 33. Lassa virus RNA detection from suspected cases in Nigeria, 2011-2017.
    Babalola SO; Babatunde JA; Remilekun OM; Amaobichukwu AR; Abiodun AM; Jide I; Adeshina AI; Chikwe I; Aremu OS
    Pan Afr Med J; 2019; 34():76. PubMed ID: 31819792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unravelling the dynamics of Lassa fever transmission with differential infectivity: Modeling analysis and control strategies.
    Musa SS; Yusuf A; Bakare EA; Abdullahi ZU; Adamu L; Mustapha UT; He D
    Math Biosci Eng; 2022 Sep; 19(12):13114-13136. PubMed ID: 36654038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria.
    Salu OB; Amoo OS; Shaibu JO; Abejegah C; Ayodeji O; Musa AZ; Idigbe I; Ezechi OC; Audu RA; Salako BL; Omilabu SA
    Pan Afr Med J; 2020; 36():253. PubMed ID: 33014249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lassa fever outbreaks in Nigeria.
    Akpede GO; Asogun DA; Okogbenin SA; Okokhere PO
    Expert Rev Anti Infect Ther; 2018 Sep; 16(9):663-666. PubMed ID: 30111178
    [No Abstract]   [Full Text] [Related]  

  • 37. Outbreak of lassa fever in Nigeria: measures for prevention and control.
    Mofolorunsho KC
    Pan Afr Med J; 2016; 23():210. PubMed ID: 27347299
    [No Abstract]   [Full Text] [Related]  

  • 38. Lassa fever outbreak continues across Nigeria.
    Bagcchi S
    Lancet Infect Dis; 2020 May; 20(5):543. PubMed ID: 32359466
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessment of antiviral therapeutics in animal models of Lassa fever.
    Warner BM; Siragam V; Stein DR
    Curr Opin Virol; 2019 Aug; 37():84-90. PubMed ID: 31357140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knowledge, Misperceptions, Preparedness, and Barriers towards Lassa Fever Control among Health Care Workers in a Tertiary Institution in Enugu, Nigeria.
    Ndu AC; Kassy WC; Ochie CN; Arinze-Onyia SU; Okeke TA; Aguwa EN; Okwor TJ; Chinawa A
    J Health Care Poor Underserved; 2019; 30(3):1151-1164. PubMed ID: 31422994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.